TrialBlood advances2020

Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia.

Jorge J Castillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.